(Reuters) -AbbVie ( ABBV ) raised its 2025 profit forecast on Friday, after strong sales of newer immunology drugs Skyrizi and Rinvoq helped boost third-quarter results above Wall Street estimates. The North Chicago-based drugmaker has been leaning on Skyrizi and Rinvoq to offset declining sales of its once best-selling arthritis treatment Humira that began facing biosimilar competition in the U.S....

Overview * Marcus fiscal Q3 revenue decreases 9.7% yr/yr, missing analyst expectations * Adjusted EBITDA for fiscal Q3 misses analyst estimates * Company repurchases $9 mln in shares, authorizes buyback of up to 4 mln additional shares Outlook * Marcus anticipates strong film slate for remainder of 2025 and into 2026 * Company expects continued strength in group business at...

07:54 AM EDT, 10/31/2025 (MT Newswires) -- Lufax Holding ( LU ) said Friday that it has appointed Xiang Ji as co-chief executive officer and Tao Wu as chief marketing officer, effective immediately. Ji most recently served at McKinsey & Company as global managing partner overseeing its Asia retail banking business, while Wu most recently served as CEO of Autohome...

07:56 AM EDT, 10/31/2025 (MT Newswires) -- Canadian National Railway ( CNI ) reported Q3 adjusted earnings Friday of 1.83 Canadian dollars ($1.31) per diluted share, up from CA$1.72 a year earlier. Analysts polled by FactSet expected CA$1.77. Revenue for the quarter ended Sept. 30 was CA$4.17 billion, up from CA$4.11 billion a year earlier. Analysts surveyed by FactSet expected...